Asian American Medical Group Ltd
ASX:AJJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/GP
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.
Valuation Scenarios
If EV/GP returns to its 3-Year Average (68.7), the stock would be worth AU$0.04 (2% downside from current price).
| Scenario | EV/GP Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 70.4 | AU$0.04 |
0%
|
| 3-Year Average | 68.7 | AU$0.04 |
-2%
|
| 5-Year Average | 66 | AU$0.04 |
-6%
|
| Industry Average | 4.6 | AU$0 |
-94%
|
| Country Average | 5.9 | AU$0 |
-92%
|
Forward EV/GP
Today’s price vs future gross profit
Peer Comparison
| Market Cap | EV/GP | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
|
Asian American Medical Group Ltd
ASX:AJJ
|
14.5m AUD | 70.4 | 695.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
105.9B USD | 2.8 | 59.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 4.1 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
76.6B USD | 0 | 12.9 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | 5.6 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 5.8 | 22.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.1B USD | 6.4 | 24.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.6B USD | 7 | 21.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 3.4 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 18.8 | -27.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 4.5 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 2.6 |
| Median | 5.9 |
| 70th Percentile | 10.3 |
| Max | 26 151.2 |
Other Multiples
Asian American Medical Group Ltd
Glance View
Asian American Medical Group Ltd. provides healthcare consultancy and management services. The firm's segments include liver, Multi-Specialty, Healthcare Management and Consultancy, and Healthcare Real Estate. The liver segment operates is engaged in the business of treatment of all liver, pancreas and bile duct diseases in adults and children. The Multi-Specialty segment is a medical specialist in Singapore and abroad, mainly in the United States and Great Britain. The Multi-Specialty, Healthcare Management and Consultancy segment is focused on sourcing and identifying potential healthcare-related projects. THe Healthcare Real Estate segment is managed under the Company’s subsidiary Asian American Healthcare Ventures Pte Ltd (AAHV).
